Publication
Pru p 3 sublingual immunotherapy ultra-rush protocol is safe and clinically effective
dc.contributor.author | Moura, AL | |
dc.contributor.author | Pereira, C | |
dc.contributor.author | Regateiro, FS | |
dc.contributor.author | Azevedo, J | |
dc.contributor.author | Todo Bom, A | |
dc.contributor.author | Carrapatoso, I | |
dc.date.accessioned | 2024-02-20T16:00:00Z | |
dc.date.available | 2024-02-20T16:00:00Z | |
dc.date.issued | 2019 | |
dc.description.abstract | Introduction. Sublingual immunotherapy (SLIT) with Pru p 3 can prevent severe allergic reactions to LTP-containing foods, but the standard initiation protocol is time-consuming. Objectives. Establish the safety of a novel ultra-rush initiation protocol for SLIT with Pru p 3. Methods. Prospective study comparing the side effects of the standard vs novel ultra-rush initiation protocols of SLIT with Pru p 3 in patients with anaphylaxis to LTP. Results. Fifteen patients were included (standard initiation, 5; ultra-rush initiation, 10), 80% females. All patients had oropharyngeal pruritus during initiation, 80% with spontaneous recovery, but no other gastro-intestinal, respiratory, cutaneous or systemic side effects occurred in any patient of both groups. Conclusion. The novel ultra-rush protocol halved the build-up time without increasing side effects. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Eur Ann Allergy Clin Immunol . 2019 Sep 16;51(5):206-212. | pt_PT |
dc.identifier.doi | 10.23822/EurAnnACI.1764-1489.99 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.4/2354 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.subject | Hipersensibilidade Alimentar | pt_PT |
dc.subject | Imunoterapia Sublingual | pt_PT |
dc.title | Pru p 3 sublingual immunotherapy ultra-rush protocol is safe and clinically effective | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.issue | 05 | pt_PT |
oaire.citation.startPage | 206 | pt_PT |
oaire.citation.title | European Annals of Allergy and Clinical Immunology | pt_PT |
oaire.citation.volume | 51 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- volume-sublingual-immunotherapy-ultrarush-protocol-safe-3211allasp1.pdf
- Size:
- 102.28 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: